Does Anastrozole Make You Tired?

Fatigue is one of the more common side effects of anastrozole, reported frequently enough in clinical trials that researchers now track it as a standard outcome. The tiredness is not just “feeling a bit run down” after a long day. For many women taking anastrozole as part of breast cancer treatment, it can be a persistent, draining exhaustion that interferes with work, exercise, and daily routines. But the experience varies widely from person to person, and the fatigue often connects to a web of other side effects rather than standing alone.

How Common Is Fatigue on Anastrozole

Clinical trials consistently place fatigue among the top-reported side effects of aromatase inhibitors like anastrozole. In a large Japanese adjuvant therapy trial comparing anastrozole to tamoxifen and exemestane, fatigue was more frequent in the anastrozole group than in the tamoxifen group.¹ The exact percentage varies across studies depending on how fatigue is measured and how long women have been on the drug, but it consistently ranks alongside joint pain and hot flashes as one of the side effects women bring up most often.

A study tracking neuropsychological symptom burden in postmenopausal women starting anastrozole found that the composite burden of symptoms like fatigue, cognitive difficulty, and sleep problems tended to creep upward over the first 18 months. But the averages masked enormous individual differences. The researchers identified five distinct trajectories: some women stayed at a low, stable level of symptoms throughout, while others started high and kept climbing.² This means blanket statements about “how tired anastrozole will make you” are misleading. Some women barely notice it, while others find it seriously debilitating.

Why Anastrozole Causes Fatigue

Anastrozole works by blocking an enzyme called aromatase, which the body uses to produce estrogen. In postmenopausal women, this is the primary remaining source of estrogen. Shutting it down drives estrogen levels extremely low, and estrogen plays roles in energy regulation, sleep quality, mood, and pain sensitivity. The fatigue people experience on anastrozole is not caused by one neat mechanism but rather by several overlapping problems that all trace back to that estrogen drop.

The most direct pathway is through sleep disruption. Hot flashes affect up to about 70% of women on adjuvant endocrine therapy, and they frequently strike at night.³ Women describe waking drenched in sweat, throwing off blankets, then getting cold, then overheating again. Even when they fall back asleep relatively quickly, the repeated interruptions prevent deep, restorative sleep. Night after night of fragmented sleep compounds into daytime fatigue that can be severe.

A second pathway runs through joint pain. One study following women during the first months of anastrozole therapy found something striking: fatigue and disturbed sleep worsened specifically in patients who developed joint pain but not in those who stayed pain-free. In women without joint pain, fatigue actually decreased after the initial adjustment period. In women with joint pain, fatigue persisted at the elevated six-week level and did not improve.⁴ This suggests that for many women, the tiredness is not caused by the drug acting directly on energy pathways but is being driven by chronic pain and the poor sleep that comes with it.

There is also a hypothesis linking aromatase inhibitors to disrupted melatonin cycles. Some researchers have proposed that when estrogen levels drop sharply, the body’s normal process of suppressing melatonin in response to light becomes less effective, potentially producing an abnormal melatonin pattern similar to what is seen in rheumatoid arthritis patients.⁵ This idea remains a hypothesis rather than an established fact, but it is one possible explanation for why some women on anastrozole feel that their sleep-wake rhythm itself feels “off,” beyond just being woken by hot flashes.

The Cognitive Fog Connection

Many women on anastrozole describe something that goes beyond simple tiredness: a mental fog, difficulty concentrating, trouble finding words, or a feeling that their thinking has slowed down. This is not imagined. Research tracking cognitive function during anastrozole therapy found measurable declines in working memory and concentration during the first six months, both in women who had previously received chemotherapy and in those taking anastrozole alone. Women in the anastrozole-only group experienced a second dip in working memory and concentration between 12 and 18 months after starting the drug.⁶

This cognitive blunting contributes to the overall feeling of fatigue in a way that is hard to separate from physical tiredness. When concentrating on a task feels like pushing through mud, even routine mental work becomes exhausting. Women who have also undergone chemotherapy before starting anastrozole may notice this more acutely, since chemotherapy can independently affect cognition. But the research shows that anastrozole alone produces measurable cognitive changes, meaning the drug itself bears some responsibility for the mental component of fatigue even in women who never had chemo.

How Does Anastrozole Compare to Tamoxifen for Fatigue

Women sometimes wonder whether switching from anastrozole to tamoxifen (or vice versa) would help with tiredness. The honest answer is that when researchers have directly compared the two drugs, fatigue and energy levels look remarkably similar between groups over the long run. A large randomized trial comparing anastrozole to tamoxifen in women with ductal carcinoma in situ found no significant difference in energy and fatigue scores, physical health scores, mental health scores, or symptoms of depression over five years of follow-up.⁷

That said, the specific side effect profile differs. Anastrozole tends to cause more joint pain and musculoskeletal stiffness, while tamoxifen causes more vaginal discharge and carries a slightly higher risk of blood clots and uterine issues.¹ So while both drugs produce fatigue at roughly similar rates on average, the underlying drivers can differ. If your fatigue on anastrozole is being fueled primarily by joint pain and stiffness, switching to tamoxifen might help with those particular symptoms even though it may introduce its own set of problems. This is a conversation worth having with an oncologist rather than a decision to make based on averages.

Who Is Most Likely to Experience Fatigue

The five-trajectory finding from the symptom burden study is worth revisiting here, because it highlights that “taking anastrozole” alone does not determine how tired you will be. Some women remain in the low-stable category for the entire duration of treatment. Others land in a high-increasing trajectory where symptoms keep getting worse over time.²

Several factors seem to push women toward the more fatigued end of the spectrum. Women who develop significant joint pain early in treatment are at higher risk of persistent fatigue, as discussed earlier.⁴ Prior chemotherapy also appears to compound the cognitive and fatigue burden. Women who were already dealing with sleep problems, depression, or chronic pain before starting anastrozole tend to have a harder time as well. Emerging research on pharmacogenomics suggests that specific genetic variants, particularly in the estrogen receptor gene ESR1, may predict who is more likely to struggle enough to discontinue treatment altogether.⁸ Genetic testing for this purpose is not yet standard practice, but it hints that some people are biologically predisposed to worse side effects from aromatase inhibitors.

Age and baseline fitness level also play a role, though in a way that is sometimes counterintuitive. Women who were more physically active before starting anastrozole do not necessarily escape fatigue, but they tend to have more resilience and more room to implement the kinds of lifestyle strategies that help manage it.

What Actually Helps With the Fatigue

The instinct when you are exhausted is to rest more, but the most consistent evidence for managing anastrozole-related fatigue actually points in the opposite direction: exercise. A systematic review of exercise interventions for breast cancer survivors on hormone therapy found that aerobic exercise provided clear improvements in both fatigue and sleep disturbances.⁹ This does not mean pushing through a grueling workout when you can barely keep your eyes open. Even moderate activity like walking, swimming, or gentle cycling has shown benefits. The exercise appears to help through multiple channels: improving sleep quality, reducing joint stiffness, boosting mood, and directly counteracting the deconditioning that happens when fatigue leads to inactivity, which in turn worsens fatigue.

When insomnia is a significant contributor to the fatigue, cognitive behavioral therapy for insomnia (CBT-I) has shown strong results. In a randomized trial of cancer survivors with insomnia, CBT-I significantly improved fatigue scores, while a wakefulness-promoting drug called armodafinil did not.¹⁰ That finding is worth highlighting because it challenges the assumption that fatigue needs a stimulant-type solution. Fixing the insomnia fixed the fatigue. CBT-I is a structured program, usually lasting several weeks, that retrains sleep habits and addresses the thought patterns that perpetuate insomnia. It is widely available now, including through telehealth programs and app-based versions.

Acupuncture is another option some women explore. A study on breast cancer patients taking aromatase inhibitors found that fatigue decreased significantly after six weeks of acupuncture treatment.¹¹ The evidence here is less robust than for exercise or CBT-I, and acupuncture trials are notoriously difficult to blind properly, but it is a low-risk option that some women find helpful, particularly if joint pain is part of their symptom picture.

Beyond formal interventions, practical strategies matter. Timing your anastrozole dose for the evening rather than the morning can sometimes reduce the impact of any acute drowsiness. Managing hot flashes aggressively, whether through cooling bedding, keeping the bedroom cold, or discussing pharmaceutical options with your doctor, can protect sleep quality. Limiting caffeine to the morning hours sounds obvious but becomes especially important when your sleep architecture is already fragile.

When Fatigue Might Not Be the Anastrozole

One trap that both patients and clinicians fall into is attributing every symptom during anastrozole therapy to the drug. Fatigue has an enormous number of potential causes, and women taking anastrozole are often in a demographic (postmenopausal, history of cancer treatment) where other explanations are common. Thyroid dysfunction, anemia, vitamin D deficiency, depression, and deconditioning from reduced activity during cancer treatment can all produce fatigue that looks and feels identical to a drug side effect.

It is worth having basic bloodwork done if fatigue is significant, particularly thyroid function and a complete blood count. Hypothyroidism, in particular, is common in postmenopausal women and produces symptoms (fatigue, mental fog, joint aches, weight gain) that overlap almost perfectly with the side effects of anastrozole. Treating a thyroid problem or correcting an iron deficiency can dramatically reduce fatigue even if anastrozole is also contributing to it.

The timeline of fatigue onset matters too. If fatigue appeared right when you started anastrozole and worsened during the first few months, the drug is a plausible cause. If fatigue has been present since chemotherapy or surgery and did not clearly change when anastrozole started, the drug may be one contributor among several rather than the main culprit.

Fatigue and the Decision to Stay on Treatment

Anastrozole is typically prescribed for five to ten years after breast cancer, and fatigue is one of the leading reasons women stop taking it early. The research on treatment discontinuation shows that side effect burden is the primary driver, with emergent symptoms like fatigue and joint pain in the early months being particularly predictive of who will eventually abandon the medication.⁸

This creates a genuine dilemma. Anastrozole reduces the risk of breast cancer recurrence, and that benefit accumulates over years of use. But a drug you cannot tolerate is a drug you stop taking, which provides zero benefit. If fatigue is seriously affecting your quality of life, the conversation with your oncologist should not be “tough it out” but rather an honest assessment of alternatives. Switching to a different aromatase inhibitor (letrozole or exemestane), switching to tamoxifen, adjusting the treatment timeline, or aggressively managing the side effects are all options that an oncologist can evaluate based on your specific cancer characteristics and risk profile.

The worst outcome is silently stopping the drug without telling your care team, which unfortunately happens frequently. If anastrozole is making you miserable, say so. The side effect landscape is different for each alternative, and what is intolerable on one drug may be manageable on another.

Anastrozole Fatigue in Men

Although anastrozole is primarily prescribed to postmenopausal women for breast cancer, it is also used off-label in men, most commonly by bodybuilders and steroid users to control estrogen levels during or after anabolic steroid cycles. The side effect experience in this population is not well studied through formal clinical trials, but forum-based research analyzing self-reported adverse effects among steroid users found that aromatase inhibitors produced musculoskeletal complaints, mood disturbances, and impaired quality of life in a notable proportion of users.¹² Fatigue is a plausible component of the “impaired quality of life” umbrella, and the mechanism would be similar: crashing estrogen levels below a functional range disrupts sleep, mood, and energy. Men using anastrozole without medical supervision often take doses and durations that have not been studied, making their side effect profile unpredictable.

Men prescribed anastrozole by a physician for conditions like hypogonadism or gynecomastia are typically on lower, more carefully monitored doses, and severe fatigue is less commonly reported in that context. But the principle remains the same: driving estrogen too low in either sex produces a cluster of symptoms that includes tiredness, joint aches, and mood changes. The difference is that men start with lower estrogen levels, so even a modest over-suppression can push them into symptomatic territory.